Drug Profile
BR 16A
Alternative Names: MentatLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Punjab University-Chandigarh
- Class Antiepileptic drugs; Anxiolytics; Neuroprotectants; Nootropics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Anxiety disorders; Cognition disorders; Seizures; Sleep disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Sleep-disorders in India (PO)
- 17 Feb 2004 Preclinical trials for Sleep disorders in India (PO)
- 17 Feb 2004 Data presented at the International Congress of Biological Psychiatry (ICBP-2004) have been added to the Anxiety Disorders pharmacodynamics section